Exchange: NASDAQ·Updated 12:00 AM EST

APLT Applied Therapeutics Inc

$0.108
$0.00
(0.00%)
Pre-Market
Prev Close $0.108
Reported EarningsNov 13
Mkt Cap$14.86M

About APLT

Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company which engages in the development of a pipeline of novel products. It is targeting treatments for central nervous system rare diseases and diabetic complications. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY.
58

Bullish Sentiment

How do you feel about APLT?

Advertisement|Remove ads.